GT199800052A - PHARMACEUTICAL COMPOSITIONS. - Google Patents

PHARMACEUTICAL COMPOSITIONS.

Info

Publication number
GT199800052A
GT199800052A GT199800052A GT199800052A GT199800052A GT 199800052 A GT199800052 A GT 199800052A GT 199800052 A GT199800052 A GT 199800052A GT 199800052 A GT199800052 A GT 199800052A GT 199800052 A GT199800052 A GT 199800052A
Authority
GT
Guatemala
Prior art keywords
pharmaceutical compositions
hydroximehylin
4amino1
novelly
epivir
Prior art date
Application number
GT199800052A
Other languages
Spanish (es)
Inventor
Ngoc-Anh Th Nguyen
Warren Michael Casey
Original Assignee
Glaxo Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Inc filed Critical Glaxo Group Inc
Publication of GT199800052A publication Critical patent/GT199800052A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS, NOVEDOSAS SUSTENCIALMENTE LIBRE DE ETANOL Y ACIDO ETILENDIAMINOTETRAACETICO, CARACTERIZADA PORQUE COMPRENDE (2R,CIS)4AMINO1(2HIDROXIMETIL1,3OXATHIOLAN5IL)(1H)PIRIMIDIN2ONA (()2',3'DIDESOXI,3'THIACITIDINA, EPIVIR(RTM), LAMIVUDINA) O UN DERIVADO FARMACEUTICAMENTE ACEPTABLE DE LA MISMA Y UN SISTEMA CONSERVADOR.THE PRESENT INVENTION IS REFERRED TO PHARMACEUTICAL COMPOSITIONS, NOVELLY SUBSTANTIALLY FREE OF ETHANOL AND ETHYLENDIAMINOTETRAACETIC ACID, CHARACTERIZED BECAUSE IT INCLUDES (2R, CIS) 4AMINO1 (2) HYDROXIMETIL1 (2) HYDROXIMEHYLIN (3) EPIVIR (RTM), LAMIVUDINE) OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF THE SAME AND A CONSERVATIVE SYSTEM.

GT199800052A 1997-03-24 1998-03-23 PHARMACEUTICAL COMPOSITIONS. GT199800052A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24

Publications (1)

Publication Number Publication Date
GT199800052A true GT199800052A (en) 1998-03-23

Family

ID=21921425

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800052A GT199800052A (en) 1997-03-24 1998-03-23 PHARMACEUTICAL COMPOSITIONS.

Country Status (2)

Country Link
GT (1) GT199800052A (en)
ZA (1) ZA982367B (en)

Also Published As

Publication number Publication date
ZA982367B (en) 1999-09-20

Similar Documents

Publication Publication Date Title
ES2184881T3 (en) PHARMACEUTICAL COMPOSITION OF ETHICAL ESTER OF L-DOPA.
WO2004041153A3 (en) Pharmaceutical composition including low dosages of desmopressin
HN1998000020A (en) ARILSULFONYL HYDROXAMIC ACID DERIVATIVES.
CA2213989A1 (en) External preparation for topical administration
BG103882A (en) Voriconazol-containing pharmaceutical compositions
FI980822A (en) Pharmaceutical composition on the skin or mucosal surface of the active substance or through the skin or mucosa surface
LU91138I2 (en) Insulin glulisine and its pharmaceutically acceptable derivatives.
LV12350A (en) Heptapeptide Oxytocin Analog
FI973363A (en) Nucleic acid composition, its preparation and use
CY1108117T1 (en) PHARMACOLOGICALLY ACTIVE COMPOUNDS WITH TWO CATHOLICALLY CONNECTED ACTIVE SATURES
LU91181I2 (en) Ziconotide, optionally in the form of a salt with a pharmaceutically acceptable acid, including ziconotide acetate (prialt).
NO953262L (en) Improvement of Dupuytren's disease
DE69637964D1 (en) Derivatives of Nodulisporen acid
PT975348E (en) STABILIZED TIBOLONE COMPOSITIONS
BG108421A (en) Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
WO2003020200A3 (en) A novel pharmaceutical compound and methods of making and using same
MY116269A (en) 5' -aminocylated-2', 3' -dideoxy -3' -fluoroguanosine hbv antivirals
RS49772B (en) Pharmaceutical compositions
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
BR9812085A (en) "method for the synthesis of quinoline derivatives"
GT199800052A (en) PHARMACEUTICAL COMPOSITIONS.
BR9807406A (en) Pharmaceutical formulation, and process for preparing them
PT1066304E (en) LHRH MACROLID ANTAGONISTS
ES2160978T3 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR PREPARATION.
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.